Table 1.
Drugs | Type | Status | Study |
---|---|---|---|
Evolocumab | Monoclonal Ab | Approved | Proficio Program |
Alirocumab | Monoclonal Ab | Approved | Odyssey Program |
Bococizumab | Monoclonal Ab | Discontinued | Spire Program |
Inclisiran | Silent RNA | On approval | Orion 1 |
LGT-209 | Monoclonal Ab | Discontinued | - |
RG7652 | Monoclonal Ab | Phase 2 | Equator |
ALN-PC | RNAinhibitor | Phase 1 ev/Preclinical sc | - |
Adnectin BMS-962476 | modified binding protein | Phase 1 | - |
EGF-A peptide | synthetic peptide | Preclinical | - |